Microbes frequently rely on metabolites excreted by other bacterial species, but little is known 1 about how this cross-feeding influences the effect of antibiotics. We hypothesized that when 2 species rely on each other for essential metabolites, the minimum inhibitory concentration (MIC) 3 for all species will drop to that of the "weakest link" -the species least resistant in monoculture. 4
occurs when metabolites produced by one organism are used as a nutrient or energy source by 50 another (Rosenzweig et al., 1994; Schink, 2002) . This phenomenon is nearly ubiquitous in 51 microbial communities (Pande et al., 2014; Seth and Taga, 2014; Zelezniak et al., 2015) and is 52 thought to contribute to our inability to cultivate most bacterial species in isolation (Kaeberlein et 53 al., 2002; Oliveira et al., 2014) . Cross-feeding has also been shown to play a critical role in the 54 human microbiome. For example, Bifidobacterium species in the gut cooperate with each other 55 to break down complex plant-based carbohydrates (Milani et al., 2015) , which releases carbon 56 for butyrate-producing bacteria. Cross-feeding in the gut also increases the efficiency of glycan 57 breakdown by removing waste products such as H2 (Koropatkin et al., 2012). Additionally, 58 cross-feeding can influence pathogen survival. For example, growth and virulence of the oral 59 pathogen Aggregatibacter actinomycetemcomitans depends on L-lactate generated by the 60 commensal Streptococcus gordonii (Stacy et al., 2016) . Given the ubiquity and importance of 61 cross-feeding in human-associated microbial communities, greater investigation in to how cross-62 feeding influences population and community responses to antibiotics is needed.
5
In this work, we test how cross-feeding changes the effect of antibiotics on bacteria in microbial 64 communities. We use the term tolerance to signify the ability of species to grow in a given 65 antibiotic concentration. Tolerance as we define it can change as a function of physiological state 66 or environmental conditions, while changes in resistance would require a change in DNA 67 sequence (Brauner et al., 2016) . We hypothesize that when species depend on one another the 68 community tolerance (i.e. the level of antibiotic required to inhibit detectable growth of the 69 community as a unit) will be set by the tolerance of the 'weakest link', or the most antibiotic-70 sensitive community member. Alternatively, community tolerance may be higher than that of the 71 weakest species in monoculture (the 'community protection' hypothesis), or lower (the 72 'community sensitivity' hypothesis). Higher than expected tolerance may occur if one or more 73 species in a community excretes a compound which either actively degrades antibiotics in the antibiotic, while not sufficient to arrest or kill any one species, sufficiently disrupt cross-feeding 78 to inhibit community growth. 79
We tested the impact of cross-feeding on tolerance in a variety of conditions. We started with an 80 engineered obligate mutualism involving Escherichia coli, Salmonella enterica serovar 81 Typhimurium, and Methylobacterium extorquens (Figure 1 , Harcombe et al, 2014). The 82 tolerance of the mutualism was compared to the tolerance of each species in monoculture. These 83 tests were done with ampicillin and tetracycline because the drugs have different mechanisms of 84 action (Perlin et al., 2009 , Hong et al., 2014 , and because ampicillin can be enzymatically 85 degraded (Munita and Arias, 2016) , allowing the potential for cross-protection of sensitive 86 6 species (Perlin et al., 2009 ). Further, we tested the impact of these antibiotics in both liquid 87 media and agar plates to test the influence of spatial structure. Finally, to test the generality of 88 our findings we investigated the effect of cross-feeding on tolerance in a model relevant for 89 cystic fibrosis. This system involves the pathogen P. aeruginosa, and a previously defined 90 anaerobic consortium of bacteria that provide carbon for the pathogen when growing on mucin 91 (Flynn et al., 2016) . 92
Across all treatments and in both the model and clinically relevant systems, resistant bacteria 93 were inhibited by lower concentrations of antibiotic when cross-feeding than when growing 94 independently. However, we found that cross-feeding can provide protection to more sensitive 95 bacteria. For both ampicillin and tetracycline, cases arose in which tolerance was higher than 96 predicted based on measurements of tolerance in monoculture. Our results demonstrate that 97 metabolic interactions impact antibiotic tolerance in a community, and suggest that antibiotic-98 resistant pathogens may be treated by targeting their less tolerant metabolic partners. an antibiotic. The inoculate size for a species was kept constant at ~10 4 in monoculture and 127 community (i.e. community treatments started with 3x more total cells than monocultures). 128
Ampicillin was used at 0, 0.2, 0.5, 1, 2, and 5 µg/mL for E. coli, S. enterica, and the 129 communities, and at 0, 2, 5, 10, 20, and 50µg/mL for M. extorquens; these concentrations 130 provided the best range of sublethal to lethal ampicillin concentrations. Tetracycline was used at 131 8 0, 1, 2, 3, 5, and 10µg/mL for E. coli, M. extorquens, and the community, and 0, 10, 20, 30, 50, 132 and 100µg/mL were used for S. enterica. 96-well plates were placed into a Tecan InfinitePro 200 133 at 30 O C for 120 hours. Measurements of OD600 were taken every 15 minutes to track overall 134 bacterial growth, and fluorescence measurements were taken to track the growth of individual 135 species. The minimum inhibitory concentration (MIC) was defined as the lowest antibiotic 136 concentration at which no growth was seen by three times the lag time of the antibiotic-free 137 control. 138 139
Solid media antibiotic susceptibility experiments 140
Resistance on plates was determined by measuring the diameter of the zone of inhibition around 141 an antibiotic containing disk. For monocultures, 150µL of log-phase culture (OD=0.5) was 142 spread on Hypho plates (1% agar) in a lawn; for communities, 150µL of culture from each 143 species was mixed, spun down, and re-suspended in 150µL of the appropriate community 144 medium before plating onto Hypho plates. Discs of filter paper 6mm in diameter were inoculated 145 with 25 µg antibiotic, and left to dry for 10 minutes. Discs were applied to the center of plates 146 with bacteria, and plates were incubated at 30 O LB and allowed then to grow while shaking aerobically at 37°C for 16 hrs. Optical densities 182 were determined using a Biotek Synergy H1 plate reader. Optical densities are given as mean 183 and standard deviation of three replicates. 184
Cross-feeding assays were performed as described previously (Flynn et al., 2016). Briefly, a 185 mucin fermenting community from freezer stock was inoculated into the minimal mucin medium 186 described above and allowed to grow for 48 hrs anaerobically at 37°C. This culture was used to 187 inoculate the lower phase (1:100 dilution) which contained 2 mL of minimal mucin medium, 1% In monoculture experiments, one species was at least 25 times more resistant than others, though 209 the most resistant species was different for each antibiotic. When grown in the presence of 210 ampicillin, M. extorquens had a median MIC of 100 g/ml, which was significantly higher than 211 the 2 g/ml and 1 g/ml necessary to inhibit E. coli and S. enterica respectively (Figure 2A , 212 P<0.0001 for each). For tetracycline, S. enterica had a median MIC of 50 g/ml (Figure 2B) . 213
This was significantly higher than the median MIC of 5g/ml in M. extorquens (P <0.0001) and 214 2 g/ml in E. coli (P <0.0001). 215
When bacteria were grown in an obligate mutualism rather than in monocultures, the amount of 216 antibiotic needed to inhibit resistant species decreased substantially. Fifty-fold less ampicillin 217 was needed to inhibit the cooperative community (1g/mL) than to inhibit M. extorquens in 218 monoculture (Figure 3A, P < 0.0001) . Similarly, the median MIC of tetracycline for S. enterica 219 12 decreased significantly from 50 g/ml in monoculture to 4 g/ml in the cooperative community 220 (Figure 3B , P <0.0001). 221
We next distinguished the effect of species interactions from community complexity by 222 measuring the MIC of the bacterial community when the species were not reliant on one another 223 for resources (Figure 1B, Figure 2) . The median MIC for resistant bacteria was not 224 significantly different in the competitive community than it was in monoculture (for M. 225 extorquens in ampicillin Figure 3A , P >0.90; for S. enterica in tetracycline, Figure 3B, P=0.80) . 226 Therefore, the decreased tolerance of resistant species to these antibiotics was a result of the 227 metabolic interdependence, rather than simply the presence of other species. 228
We also repeated monoculture and competitive community experiments using acetate as the sole 229 carbon source for S. enterica and M. extorquens to ensure that the change in carbon source 230 between treatments was not responsible for changes in tolerance (Supplementary figure 1) . We 231 found that the same qualitative patterns were observed with M. extorquens showing high 232 tolerance to ampicillin and S. enterica demonstrating high tolerance to tetracycline in both 233 monoculture and competitive community. However, we found that growth was less robust, and 234 that high initial concentrations of acetate may be toxic to M. extorquens. 235 236
Tolerance of tetracycline was higher than expected in the cross-feeding community 237
Unexpectedly, the MIC of tetracycline for the cooperative community was higher than the least 238 resistant monoculture, E. coli (median monoculture MIC 2µg/mL, median cooperative 239 community MIC 4μg/mL, P =0.0111). This effect was not due to higher starting cell density in 240 community (Supplementary fig. 3A) . We therefore suspected the increased tolerance of E. coli 241 13 in cooperative community might be due to increased lag times for E. coli in the cooperative 242 community. As tetracycline is known to rapidly break down, we predicted that the slower growth 243 in community might be protecting E. coli by allowing time for tetracycline to break down before 244 growth started. Consistent with this prediction, the time to detectable E. coli growth was 245 significantly longer in cooperative community than it was in monoculture (P = 0.003), and the 246 MIC of E. coli in monoculture increased if media containing tetracycline was allowed to sit for 247 20 hours before cells were added (Supplementary figure 3B) . Therefore, we concluded that the 248 increased tolerance of E. coli to tetracycline in cooperative community was likely influenced by 249 delayed E. coli growth relative to monoculture. 250
The competitive community appears to decrease the effective resistance of M. extorquens to 251 tetracycline. In monoculture, the tetracycline MIC for M. extorquens was 5g/ml, while in the 252 competitive community M. extorquens growth was not observed even in the absence of antibiotic 253 ( Figure 3B) . This indicates that competitive exclusion, rather than antibiotic tolerance, governs 254 the growth of M. extorquens in this context. M. extorquens was not competitively excluded in the 255 ampicillin treatments because it can grow at high ampicillin concentrations where its better 256 competitors cannot. (Supplementary figure 5) . This suggests that growth patterns of M. 257 extorquens in tetracycline are governed by competitive ability rather than resistance, while in 258 ampicillin M. extorquens experiences competitive release. 259 260
Resistant bacteria are also constrained by sensitive partners in structured environments 261
We next tested whether growth on agar plates (rather than growth in liquid media) altered the 262 impact that species interactions had on antibiotic resistance. We grew confluent bacterial lawns 263 14 and measured the zone of clearing around an antibiotic disc at the center. All discs contained 264 2.5µL of 10mg/mL antibiotic. We hypothesized that spatial structure might enhance the ability of 265 resistant bacteria to protect metabolic partners from degradable antibiotics like ampicillin, and 266 thereby eliminate the reduction of tolerance in the cross-feeding system. 267
Resistance on agar largely mirrored results from the liquid media. As in liquid, M. extorquens 268 was the most resistant monoculture on ampicillin, and S. enterica was the most resistant 269 monoculture in tetracycline (Figure 4) . Note that small clearing diameters signify high 270 resistance, so the relative rankings in Figure 4 are the inverse of (Figure 5) . In 285 both cooperative (Figure 5D ) and competitive (Figure 5E) community, E. coli and S. enterica 286 grew closer to the disk of ampicillin in co-culture than they did in monoculture (Figure 5A,B) . 287
We found that protection was not due to an increase in initial cell density on community verses 288 monoculture plates (Supplementary figure 6A) , and that M. extorquens was responsible for 289 providing the protection (Supplementary figure 5B) . Consistent with the observed cross-290 protection, ampicillin degrading β-lactamases were found in the genome of M. extorquens. 291
Further, nitrocefin disks were used to demonstrate β-lactamase activity when M. extorquens was 292 grown on agar in the presence of ampicillin (Supplementary Figure 7) . 293 294
Metabolic dependency reduces antibiotic tolerance of a pathogen 295
To test whether our findings extend to medically relevant systems, we investigated how co-296 culturing influences the effective tolerance of Pseudomonas aeruginosa to ampicillin. P. 297 aeruginosa is commonly found in the lung and is a leading cause of morbidity and mortality in 298 people with cystic fibrosis (Langton Hewer and Smyth, 2017) . Further, it was recently 299 demonstrated that P. aeruginosa can cross-feed on carbon generated by mucin-degrading 300 anaerobes (Flynn et al., 2016) . In addition to its medical relevance, this system is distinct from 301 our previous system in that the cross-feeding is not obligate (P. aeruginosa growth on mucin 302 decreases but is not abolished by the absence of the anaerobes). We tested how ampicillin 303 influenced the growth of P. aeruginosa, when grown alone on glucose versus in a cross-feeding 304 co-culture. 305
Consistent with previous findings (Krogfelt et al., 2000) , P. aeruginosa was highly resistant to 306 ampicillin in monoculture (Figure 7A) . No observable decrease in final yield was observed even 307 out to 25 g/ml of the drug. In contrast, the mucin-degrading anaerobes were inhibited by 5 308 g/ml of ampicillin. Consistent with expectations, 5µg/mL ampicillin was sufficient to 309 significantly reduce the density of P. aeruginosa grown in co-cultures on mucin, as compared to 310 P. aeruginosa growth alone (P =0.0334). Similar results were observed if the P. aeruginosa 311 monoculture was grown on mucin rather than glucose, however the maximum growth was 312 substantially lower (Supplementary Figure 8) . These data suggest that applying antibiotic to 313 inhibit the growth of cross-feeding partners can inhibit resistant species even in a non-obligate 314 cross-feeding system of clinical significance. 315 316 Discussion 317
Our results demonstrate that metabolic dependency between microbial community members 318 plays a critical role in mediating the effect of antibiotics. In both mass-action (liquid) and 319 structured (solid) environments we observed that bacterial species which show high levels of 320 tolerance to a given antibiotic in monoculture are inhibited at much lower concentrations in an 321 obligate mutualism. This was true for two antibiotics with different modes of action. Further, the 322 effect of metabolic dependence on antibiotic tolerance extended to a medically relevant system 323 with facultative cross-feeding. P. aeruginosa growth was reduced by substantially lower 324 concentrations of ampicillin when the pathogen was cross-feeding off of mucin-degrading 325 anaerobes that were sensitive to the drug. The constraint that cross-feeding places on the 326 tolerance of bacteria was consistent across drugs and microbial systems. 327
We have shown that the ability of a given bacterial species to grow in the presence of an 328 antibiotic is a combination of its intrinsic tolerance and the tolerance of species on which it relies 329 for metabolites. Dependence on other bacteria reduced the MIC of bacteria with high resistance 330 17 in monoculture. This change in MIC was driven by inhibition of a beneficial partner rather than a 331 change in the resistance of the focal species. The effective tolerance of a cross-feeding network, 332 therefore, is generally set by the 'weakest link' species; that is, the species with the lowest 333 resistance to the antibiotic, whose tolerance in community usually matches its monoculture 334 tolerance This suggests that antibiotics will often be more effective at controlling polymicrobial 335 communities where there is extensive metabolic interdependence, and that tolerance in cross-336 feeding communities can be approximated from monoculture studies. 337
Unexpectedly, we did see deviations from our weakest link hypothesis. E. coli had a higher 338 tetracycline MIC in the cross-feeding community than in monoculture, suggesting that cross-339 feeding provided some protection to E. coli. This slight, but significant, increase was likely 340 driven by an increase in time to detectable E. coli growth when cross-feeding. Tetracycline 341 breaks down rapidly, so delaying growth likely allowed microbial populations to experience 342 The constraint that cross-feeding places on antibiotic tolerance also extended to a polymicrobial 367 community relevant to cystic fibrosis. It should be noted that this system involved facultative 368 cross-feeding, so inhibiting anaerobes only reduced the yield of P. aeruginosa by two-fold. 369
While this reduction is substantially smaller than the complete elimination of growth in the precision treatments we need to be able to predict the impact of a drug on a focal population, and 385 how a drug will affect off-target members of a microbial community. Our work highlights that 386 precision microbiome management will require not only improved pharmacology but also a more 387 comprehensive understanding of ecological interactions in microbial systems. 
